Drug Topics
JANUARY 5, 2024
A model showed that if a vaccine coverage of 66% were achieved—similar to flu vaccination coverage—it could have a budget impact of $6.48 to $6.78 billion over the first RSV season.
Pharmacy Times
JANUARY 5, 2024
Investigators optimized the assay during development and qualification to be used in the clinical setting for pneumococcal conjugate vaccines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 5, 2024
As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years. Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “ authorized generic ,” essentially the same product sold under a private label.
Pharmacy Times
JANUARY 5, 2024
Findings may translate to a safe intervention for older women at risk of osteoporosis.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JANUARY 5, 2024
In December 2022, Congress repealed the “X-waiver” requirement, which had limited medical providers’ ability to prescribe buprenorphine-naloxone, one of the three medications approved by the Food and Drug Administration for the treatment of opioid use disorder. Lawmakers knew that the waiver was a major barrier to providing lifesaving medication that halves the risk of overdose to the millions of Americans needing treatment for opioid use disorder.
Pharmacy Times
JANUARY 5, 2024
In-hospital mortality and the Medicare Bundled Payments for Care Improvement (BPCI) model are not associated with changes in odds for Black individuals or female individuals.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JANUARY 5, 2024
Although machine learning models demonstrate potential to improve early detection of Alzheimer disease, sample sizes that underrepresent ethnic and racial groups result in unfairness.
STAT
JANUARY 5, 2024
Last January, I went to fill my son’s ADHD prescription and was handed a bag with an unfamiliar drug name on it. No mistake, the pharmacist tech said, it was just the generic version. I had a sinking feeling. As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic.
Fierce Pharma
JANUARY 5, 2024
Three days after the FDA included Novo Nordisk’s semaglutide treatments Ozempic and Wegovy on a list of medicines that it would monitor for side effects—one of them suicide ideation—a study of medi | Three days after the FDA included Novo Nordisk’s semaglutide treatments Ozempic and Wegovy on a list of medicines that it would monitor for side effects—one of them suicide ideation—a study of medical records of patients shows no link between use of the GLP-1 drugs and an increase in suicidal though
Drug Topics
JANUARY 5, 2024
By importing drugs in bulk from Canada, Florida aims to relieve the financial strain faced by patients who struggle to afford necessary medications.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JANUARY 5, 2024
AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.
pharmaphorum
JANUARY 5, 2024
Explore the highlights of the 2023 Benchling biotech press roundtable before Benchtalk London, showcasing cutting-edge software and innovations in the field of biotechnology.
Pharmacy Times
JANUARY 5, 2024
Conclusions could not be made regarding whether lower risk was associated with improvement in heart failure or if the success of optimal medications led to better clinical outcomes.
Drug Store News
JANUARY 5, 2024
Tom Cowhey has been named chief financial officer, and Mike Pykosz has been appointed president of health care delivery.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JANUARY 5, 2024
In his first earnings call since taking over as CEO of Walgreens, Tim Wentworth signaled the drugstore retail giant is exploring new pharmacy models as cost-plus drug pricing gains momentum. | New Walgreens CEO Tim Wentworth signaled the drugstore retail giant is exploring new pharmacy models as cost-plus drug pricing gains momentum during the company's recent first-quarter earnings call.
European Pharmaceutical Review
JANUARY 5, 2024
Under a new licensing agreement, Stemline Therapeutics, Inc., a wholly-owned subsidiary of the Menarini Group, gains the global rights to develop and commercialise a novel, small molecule KAT6A inhibitor. This treatment has potential for hormone sensitive cancers such as breast cancer, and other oncology indications. The therapeutic is designed using the artificial intelligence (AI)-platform from Insilico Medicine, the biotech company that is also part of this collaboration.
STAT
JANUARY 5, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
pharmaphorum
JANUARY 5, 2024
Gain insights from sustainability leaders in the life sciences industry on navigating the path to sustainable pharma. Learn about their efforts in addressing environmental issues, social impact, governance practices, and enhancing patient outcomes.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JANUARY 5, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we discuss why a cell therapy stalwart is pivoting, and why a Feng Zhang startup is laying off a quarter of its staff. Also, Novartis is using some of its GLP-1 windfall to invest in Flagship Pioneering startups in the cardiometabolic space.
Drug Topics
JANUARY 5, 2024
The Starlyng-1 study showed that the treatment met its primary endpoint of a one-sided Cmin of >0.80; a one-sided Cmax of <1.25; and a two-sided Cavg of 0.80-1.40, with 90% confidence limits.
Drug Store News
JANUARY 5, 2024
CVS Pharmacy's loyalty program now includes two membership tiers: ExtraCare and ExtraCare Plus.
European Pharmaceutical Review
JANUARY 5, 2024
Utilising an add-on therapy for treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals SPA has reported significant final, one-year results from its clinical trial 014/015, evaluating evenamide as an add-on therapy to antipsychotics in treatment-resistant schizophrenia (TRS). Evenamide According to Newron, evenamide is an orally available new chemical entity that normalises glutamate release induced by aberrant sodium channel activity (veratridine-stimulated).
Drug Store News
JANUARY 5, 2024
The North Jacksonville location marks BJ’s 242nd club and 37th club in Florida.
Fierce Healthcare
JANUARY 5, 2024
Elevance Health and its regional subsidiaries have filed suit against the feds, challenging changes to the methodology for Medicare Advantage star ratings that it calls "unlawful." | Elevance Health and its regional subsidiaries have filed suit against the feds, challenging changes to the methodology for Medicare Advantage star ratings that it calls "unlawful.
Drug Store News
JANUARY 5, 2024
The Aurora facility is expected to create approximately 400 new jobs, while the upgraded DG Market in Lockney, Texas, offers an expanded selection of fresh meat, dairy, produce and more.
PharmaVoice
JANUARY 5, 2024
Although three companies dominate the space, emerging infectious disease focus areas and a handful of other key players are augmenting the market.
Pharmaceutical Commerce
JANUARY 5, 2024
LillyDirect will facilitate access to medications by connecting patients with independent telehealth providers, bypassing the need to obtain a prescription from a physician and then going to a pharmacy to fill it.
Fierce Pharma
JANUARY 5, 2024
When Theravance called it quits on a phase 2 JAK inhibitor program last February, the South San Francisco and Dublin-based biopharma company put the majority of its chips on a head-to-head trial pi | In the phase 4 study, Theravance and Viatris’ Yupelri failed to demonstrate greater lung function improvement in adults with COPD versus Spiriva delivered by a dry powder inhaler, Theravance said Friday.
Drug Store News
JANUARY 5, 2024
The beauty company is kicking off the new year with the launch of its nail accents and the addition of six new shades to its Salon Effects Perfect Manicure line.
The Checkup by Singlecare
JANUARY 5, 2024
Is stomach flu going around in your school or office? When this illness hits, it causes everything from nausea to diarrhea—and if you’re not careful your entire household could easily be infected. “Another name for stomach flu is viral gastroenteritis,” says Ali A. Khan, MD , a board-certified gastroenterologist with Gastro Health in Fairfax, Virginia.
Drug Store News
JANUARY 5, 2024
The Chobani Creations Greek Yogurt line, inspired by classic desserts, is available in six flavors.
STAT
JANUARY 5, 2024
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, catch up on our reading, and take a nap or two. We also hope to hold another listening party with Mrs.
Drug Store News
JANUARY 5, 2024
The Oscar-nominated actress will help bring awareness to perimenopause and the unaddressed common experience of bladder leaks.
Expert insights. Personalized for you.
198 
Let's personalize your content